GetTopicDetailResponse(id=f9ec8e465b4, topicName=藥品研發(fā), introduction=藥品研發(fā), content=null, image=null, comments=5, allHits=1092, url=https://h5.medsci.cn/topic?id=87465, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=31466, tagList=[TagDto(tagId=31466, tagName=藥品研發(fā))], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2045687, encodeId=1121204568efa, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#藥品研發(fā)#</a>, objectTitle=通過一致性評價藥品研發(fā)費用匯總, objectType=article, longId=181901, objectId=a31d1819019c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a31d1819019c, replyNumber=0, likeNumber=88, createdTime=2020-09-24, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a31d1819019c, moduleTitle=通過一致性評價藥品研發(fā)費用匯總, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a31d1819019c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2045686, encodeId=90962045686b6, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#藥品研發(fā)#</a>, objectTitle=干細胞亂象帶來不良沖擊，專家建議借鑒藥品研發(fā)的路徑管理, objectType=article, longId=150659, objectId=528915065979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=528915065979, replyNumber=0, likeNumber=91, createdTime=2019-04-12, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=528915065979, moduleTitle=干細胞亂象帶來不良沖擊，專家建議借鑒藥品研發(fā)的路徑管理, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=528915065979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#藥品研發(fā)#</a>, objectTitle=藥品研發(fā)聚焦的十大疾病領(lǐng)域：癌癥排名**, objectType=article, longId=106262, objectId=36a110626263, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36a110626263, replyNumber=0, likeNumber=0, createdTime=2017-11-10, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36a110626263, moduleTitle=藥品研發(fā)聚焦的十大疾病領(lǐng)域：癌癥排名**, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=36a110626263)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2045685, encodeId=0591204568570, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#藥品研發(fā)#</a>, objectTitle=FDA“創(chuàng)新行動計劃”促進藥品研發(fā)與審評, objectType=article, longId=112423, objectId=6d781124231f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d781124231f, replyNumber=0, likeNumber=0, createdTime=2018-01-05, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d781124231f, moduleTitle=FDA“創(chuàng)新行動計劃”促進藥品研發(fā)與審評, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6d781124231f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2045683, encodeId=191420456834a, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#藥品研發(fā)#</a>, objectTitle=2016，中國藥品研發(fā)實力百強榜, objectType=article, longId=78573, objectId=aa66e857386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa66e857386, replyNumber=0, likeNumber=101, createdTime=2017-03-30, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa66e857386, moduleTitle=2016，中國藥品研發(fā)實力百強榜, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=aa66e857386)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
